Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2019

Jan 9, 2019

31046_dirs_2019-01-09_aba13629-a4fe-4388-b249-de885c30597f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-07

Reporting Person: Souza Marcio (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-01-07 Common Stock S 83 $34.75 Disposed 2742 Indirect

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 269 RSUs from a January 3, 2018 grant of 1,079 RSUs.

F2: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018 and 368 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018.